跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUROFEN DOUBLE STRENGTH ZAVANCE MINI LIQUID CAPSULES ibuprofen 400 mg soft capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NUROFEN DOUBLE STRENGTH ZAVANCE MINI LIQUID CAPSULES ibuprofen 400 mg soft capsule blister pack
Approved
STANDARD
NUROFEN DOUBLE STRENGTH ZAVANCE MINI LIQUID CAPSULES ibuprofen 400 mg soft capsule blister pack
Reckitt Benckiser Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b0fdd2a6fa5345d2
Company
Reckitt Benckiser Pty Ltd
Type
Standard
Approval Details
Approval Id
b0fdd2a6fa5345d2
Product Name
NUROFEN DOUBLE STRENGTH ZAVANCE MINI LIQUID CAPSULES ibuprofen 400 mg soft capsule blister pack
Artg Id
462965
Artg Name
NUROFEN DOUBLE STRENGTH ZAVANCE MINI LIQUID CAPSULES ibuprofen 400 mg soft capsule blister pack
Sponsor
Reckitt Benckiser Pty Ltd
Company Detail Path
/organization/reckitt-benckiser-australia-pty-ltd
Artg Date
2024-09-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b0fdd2a6fa5345d2
Type
Standard
Back to TGA Approvals